ArticleThe Australian & New Zealand journal of obstetrics & gynaecology2026
Clinical Pregnancy and Live Birth Outcomes From 445 Vitrified Oocyte Cycles in Australia.
Article in The Australian & New Zealand journal of obstetrics & gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo describe the outcomes for women in Australia who proceed with vitrified oocyte-thaw (VOT) cycles to achieve pregnancy.
methodOur descriptive retrospective cohort study of 445 medical and personal VOT cycles over 12 years (2009-2021) at 11 Australian IVF clinics assessed outcomes in oocyte survival, ICSI fertilisation rate, embryo utilisation rate, clinical pregnancy rate (CPR) and live birth rate (LBR), using age-stratified data (≤ 35, 35-39 and ≥ 40 years).
resultsWomen were on average 36.8 years of age (range 22-46 years) when undergoing planned oocyte cryopreservation (POC) cycles. Of the 445 VOT cycles, 4276 oocytes were warmed; 91% of oocytes survived and 63.5% fertilised normally. A total of 206 fresh embryo transfers and 253 frozen embryo transfers were performed. CPR per fresh transfer was 28% (58/206) and per frozen transfer was 35% (88/253), while LBR per fresh transfer was 24% (50/206) and per frozen transfer was 23% (57/253). The LBR after fresh transfer per VOT cycle initiated was 11% (50/445) and the LBR for combined fresh and frozen transfers was 23% (107/459) per VOT cycle initiated. Younger women at age of cryopreservation had higher pregnancy rates; LBR from combined fresh and frozen embryo transfers for women ≤ 35 years was 30.2% (38/126), for women 35-39 years was 24.1% (54/220) and for women ≥ 40 years was 14.2% (16/113).
conclusionsRates of live birth from medical VOT cycles in Australia are reasonable and decrease as women age. This information can help counsel patients on VOT-cycle outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.